{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:54:27Z","timestamp":1782474867869,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The COVID-19 pandemic highlighted the vulnerability of pregnant women and newborns, emphasizing the importance of vaccination during pregnancy to protect mothers and their infants. Maternal vaccination generates robust anti-SARS-CoV-2 IgG antibodies, transferred to the fetus through the placenta, providing neonatal protection. Breastfeeding also transfers maternal antibodies (IgA and IgG), potentially enhancing mucosal immunity. This study aimed to evaluate neonatal antibody kinetics following maternal COVID-19 vaccination, comparing vaccinated na\u00efve mothers to those previously infected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A monocentric prospective observational cohort study was conducted between July 2021 and July 2022, enrolling 44 mother-infant pairs at the Pediatrics Unit of Arzignano Cazzavillan Hospital. Eligible participants included mothers vaccinated during pregnancy (third trimester), either na\u00efve or previously infected with SARS-CoV-2. Blood and breast milk samples were collected at birth and periodically up to six months postpartum. Neonatal cord blood and subsequent samples were analyzed for anti-SARS-CoV-2 spike (S1) IgG and IgA antibodies. Statistical analyses involved parametric and non-parametric tests, with significance set at <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Out of 44 enrolled pairs, 12 breastfeeding pairs (9 na\u00efve and 3 previously infected mothers) and 3 formula-fed pairs completed the full protocol. At birth, neonates demonstrated significantly higher IgG levels than mothers, especially from na\u00efve mothers, confirming efficient transplacental antibody transfer (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Breast milk from previously infected mothers contained significantly higher IgA levels than na\u00efve mothers at all postpartum time points (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), whereas IgG levels remained stable and similar between groups. Formula-fed infants exhibited a faster decline in serum IgG compared to breastfed infants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Maternal vaccination during pregnancy induced robust transplacental IgG transfer, providing neonatal protection from birth. Breastfeeding significantly maintained neonatal IgG levels and contributed additional IgA-mediated mucosal protection, particularly following maternal infection. Formula-fed infants experienced a more rapid antibody decline. Maternal COVID-19 vaccination effectively transfers protective antibodies transplacental and through breastfeeding, suggesting its importance in prenatal care strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-02042-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:57:46Z","timestamp":1751367466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding"],"prefix":"10.1186","volume":"51","author":[{"given":"Rosa","family":"Perretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9 Borraz","family":"Torca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gasparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Rizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6113-9312","authenticated-orcid":false,"given":"Nicola Bertazza","family":"Partigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2042_CR1","doi-asserted-by":"publisher","first-page":"e3031","DOI":"10.1016\/j.ajog.2021.03.023","volume":"225","author":"KJ -Gray","year":"2021","unstructured":"Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, Baez AM, Shook LL, Cvrk D, James K, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study. Am J Obstet Gynecol. 2021;225:e3031\u201330317.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2042_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/vaccines10010125","volume":"10","author":"F -Scrimin","year":"2022","unstructured":"Scrimin F, Campisciano G, Comar M, Ragazzon C, Davanzo R, Quadrifoglio M, Giangreco M, Stabile G, Ricci G. IgG and IgA antibodies post SARS-CoV-2 vaccine in the breast milk and Sera of breastfeeding women. Vaccines (Basel). 2022;10(1):125. https:\/\/doi.org\/10.3390\/vaccines10010125. PMID: 35062786; PMCID: PMC8778843.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"2042_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/nu3040442","volume":"3","author":"WL -Hurley","year":"2011","unstructured":"Hurley WL, Theil PK. Perspectives on Immunoglobulins in colostrum and milk. Nutrients. 2011;3(4):442\u201374. https:\/\/doi.org\/10.3390\/nu3040442. Epub 2011 Apr 14. PMID: 22254105; PMCID: PMC3257684.","journal-title":"Nutrients"},{"key":"2042_CR4","doi-asserted-by":"publisher","unstructured":"Low JM, Low YW, Zhong Y, et al. Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2022;107(2):174\u2013180.https:\/\/doi.org\/10.1136\/archdischild-2021-322156. Published 2022 Jun 20.","DOI":"10.1136\/archdischild-2021-322156"},{"key":"2042_CR5","doi-asserted-by":"publisher","first-page":"e70867","DOI":"10.1371\/journal.pone.0070867","volume":"8","author":"E -Schlaudecker","year":"2013","unstructured":"Schlaudecker E, Steinhoff MC, Omer SB, McNeal MM, Roy E, Arifeen S, Dodd CN, Raqib R, Breiman RF, Zaman K. IgA and neutralizing antibodies to influenza A virus in human milk: A randomized trial of antenatal influenza immunization. PLoS ONE. 2013;8:e70867.","journal-title":"PLoS ONE"},{"key":"2042_CR6","doi-asserted-by":"publisher","unstructured":"Young BE, Seppo AE, Diaz N, et al. Association of human milk antibody induction, persistence, and neutralizing capacity with SARS-CoV-2 infection vs mRNA vaccination. JAMA Pediatr. 2022;176(2):159\u2009168. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4897","DOI":"10.1001\/jamapediatrics.2021.4897"},{"key":"2042_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-04051-6","volume":"21","author":"N -Charepe","year":"2021","unstructured":"Charepe N, Gon\u00e7alves J, Juliano AM, Lopes DG, Canh\u00e3o H, Soares H, Serrano EF. COVID-19 mRNA vaccine and antibody response in lactating women: A prospective cohort study. BMC Pregnancy Childbirth. 2021;21:1\u20139.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2042_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/17843286.2021.1943231","volume":"77","author":"L -Heireman","year":"2022","unstructured":"Heireman L, Boelens J, Coorevits L, Verhasselt B, Vandendriessche S, Padalko E. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients. Acta Clin Belg. 2022;77(3):653\u20137. https:\/\/doi.org\/10.1080\/17843286.2021.1943231","journal-title":"Acta Clin Belg"},{"key":"2042_CR9","doi-asserted-by":"publisher","unstructured":"Cavaliere AF, Marchi L, Aquilini D, Brunelli T, Vasarri PL. Passive immunity in newborn from SARS-CoV-2-infected mother. J Med Virol., Jha S, Singh A, Anant M et al. Risk of vertical transmission of SARS CoV-2 infection to neonates born to covid positive mothers: A pilot study from a tertiary care hospital of North India. J Infect Chemother. 2022;28(10):1370\u20131374. https:\/\/doi.org\/10.1016\/j.jiac.2022.06.004.","DOI":"10.1016\/j.jiac.2022.06.004"},{"issue":"18","key":"2042_CR10","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1001\/jama.2020.4861","volume":"323","author":"H -Zeng","year":"2020","unstructured":"Zeng H, Xu C, Fan J, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020;323(18):1848\u20139. https:\/\/doi.org\/10.1001\/jama.2020.4861","journal-title":"JAMA"},{"key":"2042_CR11","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2023-0089","author":"H -Karimi","year":"2023","unstructured":"Karimi H, Mansouri V, Rezaei N. Vertical transmission and maternal passive immunity post-SARS-CoV-2. Future Virol. 2023. https:\/\/doi.org\/10.2217\/fvl-2023-0089","journal-title":"Future Virol"},{"issue":"10","key":"2042_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jiac.2022.06.004","volume":"28","author":"S -Jha","year":"2022","unstructured":"Jha S, Singh A, Anant M, et al. Risk of vertical transmission of SARS CoV-2 infection to neonates born to Covid positive mothers: A pilot study from a tertiary care hospital of North India. J Infect Chemother. 2022;28(10):1370\u20134.","journal-title":"J Infect Chemother"},{"issue":"2","key":"2042_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.tjog.2022.02.005","volume":"61","author":"N -Magon","year":"2022","unstructured":"Magon N, Prasad S, Mahato C, Sharma JB. COVID-19 vaccine and pregnancy: A safety weapon against pandemic. Taiwan J Obstet Gynecol. 2022;61(2):201\u20139. https:\/\/doi.org\/10.1016\/j.tjog.2022.02.005","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"10","key":"2042_CR14","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1002\/jmv.27128","volume":"93","author":"S -Sinaci","year":"2021","unstructured":"Sinaci S, Ocal DF, Seven B, et al. Vertical transmission of SARS-CoV-2: A prospective cross-sectional study from a tertiary center. J Med Virol. 2021;93(10):5864\u201372. https:\/\/doi.org\/10.1002\/jmv.27128","journal-title":"J Med Virol"},{"issue":"14","key":"2042_CR15","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1080\/14767058.2020.1793322","volume":"35","author":"M -Deniz","year":"2022","unstructured":"Deniz M, Tezer H. Vertical transmission of SARS CoV-2: a systematic review. J Matern Fetal Neonatal Med. 2022;35(14):2655\u201362. https:\/\/doi.org\/10.1080\/14767058.2020.1793322","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"2042_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0040-1722256","volume":"43","author":"IDES -Barcelos","year":"2021","unstructured":"Barcelos IDES, Penna IAA, Soligo AG, Costa ZB, Martins WP. Vertical transmission of SARS-CoV-2: A systematic review. Transmiss\u00e3o vertical do SARS-CoV-2: Revis\u00e3o Sistem\u00e1tica. Rev Bras Ginecol Obstet. 2021;43(3):207\u201315. https:\/\/doi.org\/10.1055\/s-0040-1722256","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"12","key":"2042_CR17","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1080\/14767058.2020.1786055","volume":"35","author":"P -Thomas","year":"2022","unstructured":"Thomas P, Alexander PE, Ahmed U, et al. Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review. J Matern Fetal Neonatal Med. 2022;35(12):2387\u201394. https:\/\/doi.org\/10.1080\/14767058.2020.1786055","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2042_CR18","doi-asserted-by":"publisher","unstructured":"Wang J, Young BE, Li D, et al. Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection. Vaccines (Basel). 2022;10(6):980. Published 2022 Jun 20. https:\/\/doi.org\/10.3390\/vaccines10060980","DOI":"10.3390\/vaccines10060980"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02042-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:57:47Z","timestamp":1751367467000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02042-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02042-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hospital of Vicenza. Written informed consent was obtained from all participants or their legal guardians. The ethics approval code is 05\/22 B, date of approval 11 January 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to partecipate"}},{"value":"Consent for publication of study findings was obtained from all participants or their legal guardians at the time of enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors report no disclosures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"203"}}